DM0000: The mark consists of a stylized representation of the letter "A" adjacent to the wording "AMPHASTAR PHARMACEUTICALS, INC.".
GS0161: Printed matter, namely, brochures, leaflets, and manuals in the field of pharmaceuticals, pharmaceutical research, and healthcare
GS0051: Prescription and over-the-counter medicines, for use in connection with humans, namely, pharmaceutical preparations for treating metabolic conditions, cardiovascular conditions, allergic reactions, fertility conditions, anesthetic agents, and opioid overdose
CC0000: Color is not claimed as a feature of the mark.
DS0000: PHARMACEUTICALS and INC
Case File Event Statements
5/3/2024 - 9 months ago
1 - NEW APPLICATION ENTEREDType:NWAP
10/31/2024 - 3 months ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILEDType:MDSC
10/31/2024 - 3 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
11/19/2024 - 2 months ago
4 - ASSIGNED TO EXAMINERType:DOCK
11/23/2024 - 2 months ago
5 - NON-FINAL ACTION WRITTENType:CNRT
1/23/2025 - 18 days ago
10 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
1/23/2025 - 18 days ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
11/23/2024 - 2 months ago
6 - NON-FINAL ACTION E-MAILEDType:GNRT
11/23/2024 - 2 months ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
1/23/2025 - 18 days ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
1/27/2025 - 14 days ago
11 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA